Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Hutchison Pharmaceuticals Limited

Clinical trials sponsored by Shanghai Hutchison Pharmaceuticals Limited, explained in plain language.

Now part of HUTCHMED (China) Limited HCM NASDAQ

Develops and commercializes oncology and immunology drugs.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Completed 2

Nearly 10,000 heart attack patients to test ancient pill for better recovery

Disease control Not yet recruiting

This large study will test whether adding Shexiang Baoxin Pill (Muskardia) to standard treatment helps people who have had a heart attack. About 9,588 participants will receive either standard care alone or standard care plus the pill for 12 months. The goal is to see if the pill…

Phase: PHASE4 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control

Last updated Jun 26, 2026 13:58 UTC